ARCHIVES

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

Cancer Patient Medical history System Proposed

July 13, 1979

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

January 30, 2004

Funding Opportunities

October 11, 2002

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001